Page last updated: 2024-08-21

oxazoles and Disease, Pulmonary

oxazoles has been researched along with Disease, Pulmonary in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deshpande, D; Gumbo, T; Lee, PS; Pasipanodya, JG; Srivastava, S2
Laughon, BE; Lee, SFK; Lipman, M; McHugh, TD1
Ichikawa, K; Inagaki, T; Moriyama, M; Nakagawa, T; Nikai, T; Ogawa, K; Takahashi, H; Uchiya, K; Yagi, T1
Lewit, T1
Kaindl, F1
Buogo, A; Perrotta, P1

Reviews

2 review(s) available for oxazoles and Disease, Pulmonary

ArticleYear
New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.
    Current opinion in pulmonary medicine, 2019, Volume: 25, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nitroimidazoles; Oxazoles

2019
[Pulmonary diseases due to drugs. II].
    Harefuah, 1974, Jun-16, Volume: 86, Issue:12

    Topics: Amines; Amitriptyline; Beclomethasone; Drug-Related Side Effects and Adverse Reactions; Heroin; Humans; Hydantoins; Lung Diseases; Methadone; Naloxone; Oxazoles; Pneumonia, Aspiration; Respiratory Therapy; Sulfasalazine; Ventilators, Mechanical

1974

Other Studies

5 other study(ies) available for oxazoles and Disease, Pulmonary

ArticleYear
Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
    The Journal of antimicrobial chemotherapy, 2017, Sep-01, Volume: 72, Issue:suppl_2

    Topics: Anti-Bacterial Agents; Area Under Curve; Humans; Lung Diseases; Macrophages; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organophosphates; Oxazoles; THP-1 Cells

2017
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    The Journal of antimicrobial chemotherapy, 2017, Sep-01, Volume: 72, Issue:suppl_2

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Fluoroquinolones; Humans; Lung Diseases; Macrophages; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organophosphates; Oxazoles; Rifabutin; THP-1 Cells

2017
Characterization of a novel plasmid, pMAH135, from Mycobacterium avium subsp. hominissuis.
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Bacterial Proteins; Computational Biology; Genotype; Humans; Lung Diseases; Minisatellite Repeats; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazoles; Plasmids

2015
[Pulmonary hypertension].
    Wiener medizinische Wochenschrift (1946), 1970, Sep-19, Volume: 120, Issue:38

    Topics: Adult; Antihypertensive Agents; Appetite Depressants; Electrocardiography; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Lung Diseases; Male; Middle Aged; Oxazoles; Radiography, Thoracic

1970
[Ampicillin-dicloxacillin association in acute and chronic bronchopneumopathies. Clinical study].
    Minerva medica, 1971, Jul-11, Volume: 62, Issue:55

    Topics: Acute Disease; Adolescent; Adult; Ampicillin; Bronchitis; Bronchopneumonia; Chronic Disease; Dicloxacillin; Drug Synergism; Female; Humans; Lung Diseases; Male; Middle Aged; Oxazoles; Penicillins; Pleuropneumonia; Pneumonia

1971